A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 7/00 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2467781
The present invention relates to a method and composition utilizing monoclonal intravenous immunoglobulin (mIVIG) for increasing platelet cell counts in thrombocytopenia. The method and composition are suitable for treatments of patients suffering from medical conditions, such as idiopathic thrombocytopenic purpura (ITP), which result in low platelet cell numbers.
L'invention concerne un procédé et une composition mettant en application l'immunoglobuline intraveineuse monoclonale (mIVIG) afin d'augmenter le nombre des plaquettes dans la thrombocytopénie. Ce procédé et cette composition permettent de traiter avantageusement des patients atteints de maladies, telles que purpura thrombocytopénique idiopathique (ITP), abaissant le nombre des plaquettes.
Crow Andrew R.
Freedman John
Lazarus Alan H.
Song Seng
Canadian Blood Services
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
LandOfFree
Use of a monoclonal antibody specific for a red blood cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a monoclonal antibody specific for a red blood cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a monoclonal antibody specific for a red blood cell... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1797293